1 October 2020 - Only placebo controlled studies in the dossier. ...
1 September 2020 - Advantages in health related quality of life, symptoms and side effects outweigh disadvantages. ...
26 August 2020 - The launch marks the first European market entry for Nepexto. ...
17 August 2020 - New data from the PROSPER study shows benefit in overall survival. ...
13 August 2020 - In Germany, all new, innovative medicines are subject to an early benefit assessment by the German Federal ...
3 August 2020 - Advantages in overall survival, symptoms and health-related quality of life. ...
17 July 2020 - Dossiers submitted for early benefit assessments in Germany also provide information on the precise determination of the ...
10 July 2020 - After Germany revamped its approach to purchasing medicines a decade ago, the prices negotiated by the ...
7 July 2020 - Worldwide spending on prescription drugs has increased dramatically in recent years. Although this increase has been particularly ...
15 June 2020 - Payers are increasingly calling for the value of new drugs to be measured explicitly. ...
3 June 2020 - The German system for determining drug prices features collective negotiations on the part of competing health plans. ...
2 June 2020 - Re-valuations after the expiry of the time limit new data cuts confirm advantages and disadvantages ...
14 May 2020 - Addendum with a new summary; subsequent information enables the benefits to be assessed. ...
22 April 2020 - The European Network for Health Technology Assessment (EUnetHTA) organises an annual Forum with stakeholders to receive feedback ...
14 April 2020 - Additional donations of chloroquine sent to governments in numerous other countries. ...